Objective: The aim of this meta-analysis was to clarify the role of Matrix metalloproteinase 1 (MMP-1) -1607 1G/2G (rs1799750) polymorphism on the osteoarthritis (OA) risk. Methods: Articles were selected by retrieving the Web of Science, Embase and Pubmed. The strength of the association between -1607 1G/2G polymorphism and OA risk was assessed by odds ratios (ORs) with the corresponding 95% confidence interval (CI) for each study. Results: No significant association between -1607 1G/2G polymorphism and OA risk was found in all the models overall (2G2G vs 1G1G, OR (95%CI) ¼ 0.69 (0.36e1.32), P ¼ 0.54; 2G2G þ 2G1G vs 1G1G, OR (95% CI) ¼ 0.88 (0.47e1.63), P ¼ 0.69; 2G2G vs 2G1G þ 1G1G, OR (95%CI) ¼ 1.30 (0.68e2.47), P ¼ 0.41; 2 G vs 1G, OR (95%CI) ¼ 0.90 (0.86e1.54), P ¼ 0.66). By subgroup analysis, significant association was found in the “< 60 years” group (2G2G vs 1G1G, OR (95%CI) ¼ 3.46 (2.13e5.62), P ¼ 0.00; 2G2G þ 2G1G vs 1G1G, OR (95%CI) ¼ 0.49 (0.31e0.79), P ¼ 0.00; 2G2G vs 2G1G þ 1G1G, OR (95%CI) ¼ 2.74 (1.80e4.16, P ¼ 0.00; 2 G vs 1G, OR (95%CI) ¼ 0.56 (0.35e0.89), P ¼ 0.01). Conclusions: This meta-analysis showed that -1607 1G/2G polymorphism may increase the susceptibility to OA among the younger populations (
___
Zhang R, Yao J, Xu P, et al. A comprehensive meta-analysis of association between genetic variants of GDF5 and osteoarthritis of the knee, hip and hand. Inflamm Res. 2015;64(6):405e414.
Lepetsos P, Pampanos A, Kanavakis E, et al. Association of MMP-1 -1607 1G/2G (rs1799750) polymorphism with primary knee osteoarthritis in the Greek population. J Orthop Res. 2014;32(9):1155e1160.
Kaspiris A, Khaldi L, Grivas TB, et al. Subchondral cyst development and MMP-1 expression during progression of osteoarthritis: an immunohistochemical study. Orthop Traumatol Surg Res. 2013;99(5):523e529.
Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4(3): 157e164.
Fernandes JC, Martel-Pelletier J, Lascau-Coman V, et al. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol. 1998;25(8): 1585e1594.
Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44(3): 585e594.
Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 2000;6(12):4823e4830.
Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58(23):5321e5325.
Arakaki PA, Marques MR, Santos MC. MMP-1 polymorphism and its relationship to pathological processes. J Biosci. 2009;34(2):313e320.
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Osteoarthritis susceptibility loci defined by genome scan meta-analysis. Rheumatol Int. 2006;26(11):959e963.
MacGregor AJ, Spector TD. Twins and the genetic architecture of osteoarthritis. Rheumatology (Oxford). 1999;38(7):583e588.
Bijkerk C, Houwing-Duistermaat JJ, Valkenburg HA, et al. Heritabilities of radiologic osteoarthritis in peripheral joints and of disc degeneration of the spine. Arthritis Rheum. 1999;42(8):1729e1735.
Valdes AM, Doherty M, Spector TD. The additive effect of individual genes in predicting risk of knee osteoarthritis. Ann Rheum Dis. 2008;67(1):124e127.
Barlas IO, Sezgin M, Erdal ME, et al. Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int. 2009;29(4):383e388.
Yang HY, Chuang SY, Fang WH, et al. Effect of RAGE polymorphisms on susceptibility to and severity of osteoarthritis in a Han Chinese population: a casecontrol study. Genet Mol Res. 2015;14(3):11362e11370.
Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou EA. Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis. Genet Test Mol Biomarkers. 2012;16(1): 15e20.
Luo S, Deng M, Long X, Li J, Xu L, Fang W. Association between polymorphism of MMP-1 promoter and the susceptibility to anterior disc displacement and temporomandibular joint osteoarthritis. Arch Oral Biol. 2015;60(11): 1675e1680.
Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 1997;40(11):2065e2074.
Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum. 2001;44(12): 2777e2789.
Zeggini E, Panoutsopoulou K, Southam L, et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet. 2012;380(9844):815e823.